Profile

The laboratory currently focuses on developing Nucleic acid-based vaccines for viral infections with a particular focus on Dengue virus. Our lab's long-standing research interest is to create an innovative approach to design vaccine antigen libraries for emerging/re-emerging viral threats and their pre-clinical assessment employing new vaccine technologies in conjunction with academic-industry vaccine research collaborative initiatives. We also focus on building a clinical cohort to understand human immune responses to vaccines and natural infections.